loading...| Preferred Name | nelfinavir mesylate | |
| Synonyms |
Viracept |
|
| Definitions |
The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1624" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1624" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000042694 |
|
| altLabel |
Viracept |
|
| CAS Registry |
159989-65-8 |
|
| cui |
C0886530 C0525004 |
|
| definition |
The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1624" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1624" NCI Thesaurus) |
|
| Legacy PDQ ID |
6484 |
|
| LT |
TRD |
|
| NCI ID |
C1624 |
|
| notation |
CDR0000042694 |
|
| NSC Code |
722664 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
nelfinavir mesylate |
|
| tui |
T109 T121 |